• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

YAP1::NR4A3 and YAP1::NCOA2 fusions in poroma: expanding the spectrum of molecular alterations in poroid tumors.

作者信息

Secco Léo-Paul, Libbrecht Louis, Bonny Michiel, Lepine Charles, Švajdler Marián, Tallet Anne, Chantreau Paul-Louis, Cormier Benedicte, Cribier Bernard, Siozopoulou Vasiliki, Kervarrec Thibault

机构信息

Department of Pathology, Cliniques Universitaires Saint-Luc, B-1200, Brussels, Belgium.

Department of Pathology, AZ Groeninge, B-1200, Kortrijk, Belgium.

出版信息

Virchows Arch. 2024 Oct;485(4):749-753. doi: 10.1007/s00428-024-03898-2. Epub 2024 Aug 23.

DOI:10.1007/s00428-024-03898-2
PMID:39222124
Abstract
摘要

相似文献

1
YAP1::NR4A3 and YAP1::NCOA2 fusions in poroma: expanding the spectrum of molecular alterations in poroid tumors.汗孔瘤中的YAP1::NR4A3和YAP1::NCOA2融合：扩大类汗孔瘤肿瘤分子改变的谱
Virchows Arch. 2024 Oct;485(4):749-753. doi: 10.1007/s00428-024-03898-2. Epub 2024 Aug 23.
2
Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.具有YAP1融合的多孔性附属器皮肤肿瘤表现出相似的组织病理学特征：一组6例YAP1重排的附属器皮肤肿瘤。
J Cutan Pathol. 2021 Sep;48(9):1139-1149. doi: 10.1111/cup.14008. Epub 2021 Mar 21.
3
Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.对 NUT 阳性汗孔瘤和汗孔癌的分子分析确定了 YAP1::NUTM1 融合的新断点。
J Cutan Pathol. 2022 Oct;49(10):850-858. doi: 10.1111/cup.14265. Epub 2022 Jul 12.
4
Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.具有新型 YAP1::MAML3 融合的梭形细胞癌。
J Cutan Pathol. 2024 Mar;51(3):226-229. doi: 10.1111/cup.14575. Epub 2023 Dec 13.
5
NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.NUT 是 YAP1-NUTM1 重排皮肤毛囊瘤的特异性免疫组化标志物。
Am J Surg Pathol. 2021 Sep 1;45(9):1221-1227. doi: 10.1097/PAS.0000000000001693.
6
YAP1::MAML2 fusions in poromatosis: A report of two patients.YAP1::MAML2 融合在毛发上皮瘤病中的作用：两例患者的报告。
J Cutan Pathol. 2023 Aug;50(8):695-701. doi: 10.1111/cup.14401. Epub 2023 Feb 20.
7
NUT Expression Is of Diagnostic Utility in the Distinction of Digital Papillary Carcinoma From Poroid Hidradenoma.NUT 表达在鉴别指状突状细胞癌与多孔性汗腺瘤中具有诊断效用。
Am J Dermatopathol. 2024 Feb 1;46(2):98-100. doi: 10.1097/DAD.0000000000002596. Epub 2023 Nov 14.
8
Cuticular Poroma: A Rare Poroma Variant Simulating a Malignant Neoplasm That Often Harbors YAP1::NUTM1 Fusions Similar to Their Conventional Counterparts.角化性汗孔瘤：一种罕见的汗孔瘤变异型，模拟恶性肿瘤，常携带 YAP1::NUTM1 融合，类似于其常规对应物。
Am J Dermatopathol. 2023 Aug 1;45(8):544-548. doi: 10.1097/DAD.0000000000002465. Epub 2023 Jun 15.
9
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.在汗管瘤和汗管癌中反复出现的 YAP1-MAML2 和 YAP1-NUTM1 融合。
J Clin Invest. 2019 May 30;129(9):3827-3832. doi: 10.1172/JCI126185.
10
Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.不同的调控机制导致了毛发上皮瘤、毛母质癌和 RB1 缺失型皮肤癌中 YAP1 表达的丧失。
Histopathology. 2023 May;82(6):885-898. doi: 10.1111/his.14874. Epub 2023 Feb 22.

本文引用的文献

1
Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.具有新型 YAP1::MAML3 融合的梭形细胞癌。
J Cutan Pathol. 2024 Mar;51(3):226-229. doi: 10.1111/cup.14575. Epub 2023 Dec 13.
2
Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.痣样瘤、癌样痣和相关附属器皮肤肿瘤中的基因融合：最新进展。
Histopathology. 2024 Jan;84(2):266-278. doi: 10.1111/his.15023. Epub 2023 Aug 23.
3
Genetics of adnexal tumors: An update.附件肿瘤的遗传学：更新。
Ann Dermatol Venereol. 2023 Sep;150(3):202-207. doi: 10.1016/j.annder.2023.03.003. Epub 2023 Jun 1.
4
Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation.具有毛囊皮脂腺分化的汗孔瘤中PAK2重排复发
Histopathology. 2023 Aug;83(2):310-319. doi: 10.1111/his.14940. Epub 2023 May 18.
5
VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.VGLL2-NCOA2 利用发育程序促进儿科肉瘤发生。
Cell Rep. 2023 Jan 31;42(1):112013. doi: 10.1016/j.celrep.2023.112013. Epub 2023 Jan 18.
6
Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.骨外黏液样软骨肉瘤中新型PGR-NR4A3融合基因的鉴定及患者从他莫昔芬治疗中获得的益处
JCO Precis Oncol. 2022 Aug;6:e2200039. doi: 10.1200/PO.22.00039.
7
NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.NUT 是 YAP1-NUTM1 重排皮肤毛囊瘤的特异性免疫组化标志物。
Am J Surg Pathol. 2021 Sep 1;45(9):1221-1227. doi: 10.1097/PAS.0000000000001693.
8
The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer.孤儿核受体 4A（NR4A）在癌症中的矛盾作用。
Mol Cancer Res. 2021 Feb;19(2):180-191. doi: 10.1158/1541-7786.MCR-20-0707. Epub 2020 Oct 26.
9
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma.致癌孤儿核受体NR4A3在腺泡细胞癌中与MYB相互作用并协同发挥作用。
Cancers (Basel). 2020 Aug 27;12(9):2433. doi: 10.3390/cancers12092433.
10
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.在汗管瘤和汗管癌中反复出现的 YAP1-MAML2 和 YAP1-NUTM1 融合。
J Clin Invest. 2019 May 30;129(9):3827-3832. doi: 10.1172/JCI126185.